Keywords: لوودوپا; Pathology; Substantia nigra; Lewy bodies; l-dopa; Levodopa; Dopamine; Genetics; Alpha-synuclein; Rogue protein; Deep brain stimulation;
مقالات ISI لوودوپا (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: لوودوپا; Parkinson's disease; Gait; Levodopa; Subtypes;
Keywords: لوودوپا; Sodium alginate; Xanthan gum; Static magnetic field; Magnetic hydrogel; Levodopa; Drug release; Neural cell;
Keywords: لوودوپا; Parkinson's disease; Levodopa; Voice quality; Acoustics; Hypokinetic dysarthria;
Keywords: لوودوپا; Parkinson's disease; Levodopa; Dyskinesia; Nicotine; Dopamine;
Keywords: لوودوپا; Movement-related cortical potential; Bereitschaftspotential; Central adaptation; Levodopa; Parkinson disease;
Keywords: لوودوپا; Dyskinesia; Parkinson's disease; Levodopa; Nitric oxide; NOS1 gene; LID; Levodopa-induced dyskinesia; PD; Parkinson's disease; MDS-UPDRS; International Parkinson and Movement Disorders Society - Unified Parkinson's Disease Rating Scale; SNP; single nucleo
Keywords: لوودوپا; Parkinson's disease; Non-motor symptoms; Behavior; Levodopa; Dopamine agonists;
Keywords: لوودوپا; Parkinson disease; Levodopa; Prospective studies; Follow-up studies; Surveys and questionnaires; Incidence;
Keywords: لوودوپا; Levodopa; Intranasal powder; Chitosan; Sodium hyaluronate; Dry milling; Quality-by-design; in vitro dissolution and permeability;
Keywords: لوودوپا; Tyrosine; Tyrosine hydroxylase; Levodopa; Biosensor; High tyrosine foods;
Keywords: لوودوپا; Aging; Dopamine; Levodopa; Reversal learning; Reward; Striatum;
Keywords: لوودوپا; Parkinson's; Stem cells; Dopamine neuron grafting; Levodopa; Neuro-protection; Micro-biota;
Keywords: لوودوپا; Parkinson's disease; Hospitalization; Medication errors; Metoclopramide; Haloperidol; Levodopa; Inappropriate prescription;
Keywords: لوودوپا; Parkinson's disease; Late-stage; Levodopa; Non-motor symptoms;
Keywords: لوودوپا; Parkinson's disease; Pregnancy; Women; Levodopa;
Keywords: لوودوپا; Human serum albumin; Levodopa; Thioflavin T; Isothermal titration calorimetry; Molecular docking;
Keywords: لوودوپا; Parkinson's disease; Diet; Gastrointestinal dysfunction; Body weight; Levodopa; Motor fluctuations;
Keywords: لوودوپا; DA; dopamine; i.c.v; intra-cerebro-ventricular; l-dopa; levodopa; MPTP; 1 méthyl-4-phenyl-1,2,3,6 terahydropyridine; 6-OHDA; 6-hydroxydopamine; PD; Parkinson's disease; SMBS; sodium metabisulfite; SNpc; substantia nigra pars compacta; Parkinson's disease
Keywords: لوودوپا; Myelinolysis; Osmotic demyelination; Tremor; Parkinsonism; Dyskinesias; Levodopa;
Keywords: لوودوپا; Cognition; Dopamine; Levodopa; Parkinson's disease; Stimulus-response learning; Striatum;
Keywords: لوودوپا; Entacapone; Levodopa; Carbidopa; Partial least squares; Spectrophotometry;
Keywords: لوودوپا; best-worst scaling; conjoint analysis; deep brain stimulation; discrete-choice experiment; levodopa; Parkinson disease; patient preference;
Keywords: لوودوپا; ANOVA; analysis of variance; DD; constant darkness; EEG; electroencephalography; HD; Huntington's disease; HPA axis; hypothalamic-pituitary-adrenal axis; LD; light-dark; L-DOPA; levodopa; REM sleep; rapid eye movement sleep; SCN; suprachiasmatic nucleus;
Keywords: لوودوپا; Exercise; Plasticity; Implicit learning; Declarative learning; Dopamine; Levodopa;
Keywords: لوودوپا; L-dopa; levodopa; DA; dopamine; GCI/R; global cerebral ischemia/reperfusion model modified neurological severity score mNSS; 4-VO; four-vessel occlusion; Levodopa; Cerebral ischemia-reperfusion injury; Learning; Memory; Behavior; Morris water maze;
Keywords: لوودوپا; Parkinson's disease; Levodopa; Postural strategy;
Keywords: لوودوپا; Levodopa; Parkinson disease; Pharmacotherapy; Drug delivery;
Keywords: لوودوپا; Apomorphine; Levodopa; History;
Keywords: لوودوپا; Fullerene-functionalized carbon nanotubes; Nanocomposite; Levodopa; Acetaminophen
Keywords: لوودوپا; Dyskinesia; Levodopa; Motor Fluctuations; Parkinson's Disease; AR; Akinesia/rigidity; CI; confidence interval; DA; dopaminergic agonists; DFS; dyskinesias-free survival; DK; dyskinesia; MC; motor complications; MF; motor fluctuation; MFFS; motor fluctuati
Keywords: لوودوپا; Cobalamine; Levodopa; Neuropathy; Parkinson’s disease
Keywords: لوودوپا; Peripheral neuropathy; Parkinson's disease; Levodopa; Iatrogenic;
Keywords: لوودوپا; Parkinson's disease; Hypersexuality; Impulse control disorders; Dopamine replacement therapy; Levodopa; Dopamine agonists
Keywords: لوودوپا; Levodopa; Dopamine agonists; Clinical trial;
Keywords: لوودوپا; NET; neuroendocrine tumors; GI; gastrointestinal track; CgA; chromogranin A; BA; biogenic amines; 5-HT; 5-hydroxytryptamine (serotonin); A; adrenaline; NA; noradrenalin; DA; dopamine; NBL; neuroblastoma; 5-HIAA; 5-hydroxyindoleacetic acid; CAT; catecholam
Keywords: لوودوپا; Parkinson disease; Rat; Ultrasonic vocalization; Levodopa; Vocal exercise; 6-OHDA
Keywords: لوودوپا; Levodopa; HRP biosensor; Carbon nanotube; Nucleophilic functionalized carbon nanotube; p-Phenylynediamine;
Keywords: لوودوپا; Parkinson's disease; Levodopa; Dopamine agonist; Monoamine oxidase B inhibitors; Cathecol-O-methyltransferase inhibitors; Anticholinergics; Amantadine;
Keywords: لوودوپا; Parkinson's disease; Functional connectivity; Speech prosody; fMRI; Resting state; Dopaminergic; Levodopa; Acoustic; Motor speech network; Caudate nucleus;
Keywords: لوودوپا; Amblyopia; Patching; Atropine; Pediatric ophthalmology; Levodopa; Acupuncture; Binocular amblyopia treatment;
Keywords: لوودوپا; Parkinson's disease; Levodopa; Pramipexole; Transcriptome; Striatum; Differential transcript expression patterns6-OHDA, 6-hydroxydopamine; DA, dopamine; Gabarap, Gamma-aminobutyric acid receptor-associated protein; GAPDH, Glyceraldehyde 3-phosphate dehydr
Keywords: لوودوپا; Enfermedad de Parkinson; manifestaciones motoras; síntomas no motores; diagnóstico; tratamiento; levodopaParkinson's disease; motor features; non-motor features; diagnosis; treatment; levodopa
Keywords: لوودوپا; PD; Parkinson's disease; LD; Levodopa; MP; Mucuna pruriens; DDCI; dopa-decarboxylase inhibitor; Parkinson's disease; Mucuna pruriens; Levodopa;
Keywords: لوودوپا; Biosensor; Galvanic replacement; Gold and palladium nanoparticles; Levodopa; Nanoporous stainless steel; Uric acid;
Keywords: لوودوپا; Deep brain stimulation; Effect size; Levodopa; Parkinson disease; Prognosis; Subthalamic nucleusη2, Effect size; ADL, Activities of daily living; DBS, Deep brain stimulation; LED, Levodopa-equivalent dose; LD, Levodopa; PD, Parkinson disease; PIGD, Postur
Keywords: لوودوپا; Parkinson's disease; Otoacoustic emission; Cochlea; Levodopa; Hearing;
Keywords: لوودوپا; SpinalMouse; Levodopa; Posture; Fluctuations;
Keywords: لوودوپا; Constipation; Parkinson's disease; Parkinson; Beta-blockers; Levodopa; Dopamine agonists
Keywords: لوودوپا; Levodopa; Carbidopa; Uridine; Genotoxicity; Micronuclei; Comet;